Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Generic Oncology Sterile Injectable market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Generic Oncology Sterile Injectablemarket, defines the market attractiveness level of Generic Oncology Sterile Injectable market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Generic Oncology Sterile Injectable industry, describes the types of Generic Oncology Sterile Injectable market, the applications of major players and the market size, and deeply analyzes the current situation of the global Generic Oncology Sterile Injectable market and the development prospects and opportunities of Generic Oncology Sterile Injectable industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Generic Oncology Sterile Injectable market in Chapter 13.
By Player:
Eli Lilly & Company
Biocon Ltd
Pfizer Inc
Sandoz International GmbH
Teva Pharmaceutical Industries Ltd
Mylan NV
Baxter International Inc
Hikma Pharmaceuticals PLC
By Type:
Chemotherapy
Monoclonal Antibodies
Cytokines
Peptide Hormones
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Generic Oncology Sterile Injectable Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Generic Oncology Sterile Injectable Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Generic Oncology Sterile Injectable Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Generic Oncology Sterile Injectable Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Generic Oncology Sterile Injectable Market Analysis and Outlook to 2022
-
7.1 Global Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.2 United States Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.3 Europe Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.4 China Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.5 Japan Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.6 India Generic Oncology Sterile Injectable Consumption (2017-2022)
-
7.7 South Korea Generic Oncology Sterile Injectable Consumption (2017-2022)
8 Region and Country-wise Generic Oncology Sterile Injectable Market Analysis and Outlook to 2028
-
8.1 Global Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.2 United States Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.3 Europe Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.4 China Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.5 Japan Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.6 India Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
-
8.7 South Korea Generic Oncology Sterile Injectable Consumption Forecast (2022-2028)
9 Global Generic Oncology Sterile Injectable Market Outlook by Types and Applications to 2022
-
9.1 Global Generic Oncology Sterile Injectable Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cytokines Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Peptide Hormones Consumption and Growth Rate (2017-2022)
-
9.2 Global Generic Oncology Sterile Injectable Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Generic Oncology Sterile Injectable Market Outlook by Types and Applications to 2028
-
10.1 Global Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Peptide Hormones Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Generic Oncology Sterile Injectable Import and Export Analysis (Top 5 Countries)
-
11.1 Global Generic Oncology Sterile Injectable Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Generic Oncology Sterile Injectable Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Generic Oncology Sterile Injectable Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Generic Oncology Sterile Injectable Market Competitive Analysis
-
14.1 Eli Lilly & Company
-
14.1.1 Eli Lilly & Company Company Details
-
14.1.2 Eli Lilly & Company Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly & Company Generic Oncology Sterile Injectable Product and Service
-
14.2 Biocon Ltd
-
14.2.1 Biocon Ltd Company Details
-
14.2.2 Biocon Ltd Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biocon Ltd Generic Oncology Sterile Injectable Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Generic Oncology Sterile Injectable Product and Service
-
14.4 Sandoz International GmbH
-
14.4.1 Sandoz International GmbH Company Details
-
14.4.2 Sandoz International GmbH Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sandoz International GmbH Generic Oncology Sterile Injectable Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd Generic Oncology Sterile Injectable Product and Service
-
14.6 Mylan NV
-
14.6.1 Mylan NV Company Details
-
14.6.2 Mylan NV Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan NV Generic Oncology Sterile Injectable Product and Service
-
14.7 Baxter International Inc
-
14.7.1 Baxter International Inc Company Details
-
14.7.2 Baxter International Inc Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Baxter International Inc Generic Oncology Sterile Injectable Product and Service
-
14.8 Hikma Pharmaceuticals PLC
-
14.8.1 Hikma Pharmaceuticals PLC Company Details
-
14.8.2 Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Generic Oncology Sterile Injectable
-
Figure Generic Oncology Sterile Injectable Picture
-
Table Global Generic Oncology Sterile Injectable Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Generic Oncology Sterile Injectable Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Generic Oncology Sterile Injectable Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Generic Oncology Sterile Injectable Consumption by Country (2017-2022)
-
Figure United States Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Table Europe Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Figure China Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Figure Japan Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Figure India Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Figure South Korea Generic Oncology Sterile Injectable Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Oncology Sterile Injectable Consumption Forecast by Country (2022-2028)
-
Figure United States Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Generic Oncology Sterile Injectable Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokines Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptide Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Generic Oncology Sterile Injectable Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Generic Oncology Sterile Injectable Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly & Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly & Company Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly & Company Generic Oncology Sterile Injectable Product and Service
-
Table Biocon Ltd (Foundation Year, Company Profile and etc.)
-
Table Biocon Ltd Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Ltd Generic Oncology Sterile Injectable Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Generic Oncology Sterile Injectable Product and Service
-
Table Sandoz International GmbH (Foundation Year, Company Profile and etc.)
-
Table Sandoz International GmbH Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz International GmbH Generic Oncology Sterile Injectable Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Generic Oncology Sterile Injectable Product and Service
-
Table Mylan NV (Foundation Year, Company Profile and etc.)
-
Table Mylan NV Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Generic Oncology Sterile Injectable Product and Service
-
Table Baxter International Inc (Foundation Year, Company Profile and etc.)
-
Table Baxter International Inc Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Inc Generic Oncology Sterile Injectable Product and Service
-
Table Hikma Pharmaceuticals PLC (Foundation Year, Company Profile and etc.)
-
Table Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Pharmaceuticals PLC Generic Oncology Sterile Injectable Product and Service
-
